Quantitative Systematic Strategies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Quantitative Systematic Strategies’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-35,200	Closed	-$1.17M	–	776
2020 Q2	$1.17M	Buy	35,200 +25,550	+265%	+$814K	0.23%	142
2020 Q1	$262K	Sell	9,650 -15,105	-61%	-$421K	0.21%	170
2019 Q4	$488K	Buy	24,755 +8,964	+57%	+$143K	0.07%	343
2019 Q3	$205K	Buy	15,791 +801	+5%	+$9.67K	0.05%	407
2019 Q2	$187K	Buy	+14,990	New	+$199K	0.04%	418
2019 Q1	–	Sell	-19,151	Closed	-$211K	–	752
2018 Q4	$211K	Buy	+19,151	New	+$267K	0.05%	511
2018 Q2	–	Sell	-13,993	Closed	-$254K	–	851
2018 Q1	$254K	Buy	+13,993	New	+$233K	0.05%	503
2016 Q3	–	Sell	-15,394	Closed	-$163K	–	551
2016 Q2	$163K	Sell	15,394 -2,674	-15%	-$27.6K	0.08%	372
2016 Q1	$161K	Buy	+18,068	New	+$194K	0.06%	266
2014 Q2	–	Sell	-11,697	Closed	-$163K	–	363
2014 Q1	$163K	Buy	+11,697	New	+$198K	0.13%	263

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Quantitative Systematic Strategies's MNTA Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 35,200 shares — an estimated $1.17M sold.

Quantitative Systematic Strategies first reported a position in MNTA in Q1 2014 and held it in 10 quarters. The position peaked at $1.17M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Quantitative Systematic Strategies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 35,200 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.17M.
Quantitative Systematic Strategies first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
Quantitative Systematic Strategies's Momenta Pharmaceuticals, Inc. position peaked at $1.17M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.